Published Date: 10 Mar 2023
According to a recent report by the World Economic Forum, global factors such as the rising cost of living, the COVID-19 pandemic and climate change...
Read Full NewsTransforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols
Not surprisingly, trust in government health agencies for cancer info has dipped
Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC
News, features, and commentary about cancer-related issues
Observational study shows greater microplastic burden in patients with lung malignancy
Health news and commentary gathered by MedPage Today staff
The health ramifications of the attack persist
1.
Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers
2.
High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
5.
Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
1.
Understanding Colon Cancer: Symptoms, Causes, and Treatment Options
2.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
3.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
4.
Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion
5.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Understanding the Role of Screening in Cancer Prevention
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation